Tvardi Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need.
Tvardi Therapeutics stock last closed at $17.47, up 2.53% from the previous day, and has increased 99.32% in one year. It has overperformed other stocks in the Biotechnology industry by 1.77 percentage points. Tvardi Therapeutics stock is currently +545.13% from its 52-week low of $2.71, and -31.57% from its 52-week high of $25.53.
There are currently 4.57M shares of TVRD outstanding. The market value of TVRD is $79.90M. In the past 24 hours, 10,303 TVRD shares were traded.
How to Buy Tvardi Therapeutics Stock
Not sure how to invest in Tvardi Therapeutics stock? Here's how.
Choose where to buy Tvardi Therapeutics stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you decide where to buy Tvardi Therapeutics stock.
Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit funds into your brokerage account: Select your payment method and add your information.
Evaluate Tvardi Therapeutics stock: The Tvardi Therapeutics ticker symbol is TVRD. Is Tvardi Therapeutics stock a good investment? Should you buy shares of TVRD? How do TVRD's underlying business fundamentals look? Do top analysts think Tvardi Therapeutics is a good buy? Why has TVRD's stock price moved recently? (Hint: Our stock research website can help you understand if TVRD is a good stock to buy).
Make your TVRD buy order: Decide if you will purchase TVRD shares at the current market price or use a limit order to buy TVRD shares at a given price.
Get key alerts regarding your TVRD position: Create a watchlist to track your position in Tvardi Therapeutics stock.
Step 1: Choose where to buy Tvardi Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy TVRD shares.
A brokerage account is an investment account that enables you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
Invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to global financial markets: From Technology to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've picked the right brokerage, you'll need to fill out some personal details so you are able to invest in TVRD today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Tvardi Therapeutics stock
After you have identified the best place to buy Tvardi Therapeutics stock, it's crucial to evaluate their stock before you buy, so you actually wrap your head around the risk as well as the opportunity.
Overview of key TVRD info
TVRD Price
$17.47
1w %
214.77%
1y %
99.32%
5y %
-90.56%
P/E
-1.12x
P/B
-17.4x
P/S
11.17x
PEG
N/A
Revenue
$7.14M
Earnings
-$70.87M
Fore. Rev. Growth
44.94%
Fore. Earn. Growth
N/A
Market Cap
$79.90M
Next Earnings
May 12, 2025
Next Dividend
N/A
Tvardi Therapeutics Due Diligence Score
WallStreetZen was created to help average investors do more accurate fundamental analysis in less time.
Last year, TVRD revenue was $7.14M. During the last 5 year, TVRD's revenue has increased by -18.53% per year. This was slower than the Biotechnology industry average of 44.31%.
No, Tvardi Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about TVRD?
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your TVRD buy order
There are two main types of orders:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are usually the best for newer investors.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at a particular dollar amount limit, use a limit order.
Click the Open Trade button and your broker will place your order.
If you want more help investing in stocks on eToro, watch the how to video below:
How much does it cost to buy one Tvardi Therapeutics share?
As of Apr 21, 2025, it costs $17.47 to buy one share of Tvardi Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $8, you can buy 0.458 shares of TVRD.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.